Literature DB >> 10706060

Graft-versus-host-disease-associated thymic damage results in the appearance of T cell clones with anti-host reactivity.

M R van den Brink1, E Moore, J L Ferrara, S J Burakoff.   

Abstract

BACKGROUND: We studied whether T-cell clones, which appear in the periphery as a result of the failure of thymic negative selection during graft-versus-host disease (GVHD), have any in vivo anti-host reactivity and can cause GVHD in an adoptive transfer model.
METHODS: We performed our studies in a murine model (B10.BR into CBA/J) for allogeneic bone marrow transplantation with major histocompatibility complex-matched and minor histocompatibility antigen-mismatched unrelated donors and unique Vbeta T-cell deletion patterns in donors and recipients.
RESULTS: GVHD resulted in the appearance of Vbeta6+ T cells as a result of a loss of negative selection. We found that Vbeta6+ T cells from normal donors proliferated in vitro and in vivo. Depletion of Vbeta6+ T cells from the donor T-cell inoculum resulted in less GVHD morbidity and a decrease in the loss of thymic cellularity. To test the anti-host reactivity of de novo generated Vbeta6+ T cells in animals with GVHD, we developed an adoptive transfer model of splenic T cells from CBA/J host animals with GVHD into sublethally irradiated CBA/J recipients Depletion of Vbeta6+ T cells from the splenic T cells before adoptive transfer could significantly decrease the transient GVHD morbidity in the sublethally irradiated hosts.
CONCLUSIONS: Our data indicate that GVHD-associated thymic damage results in a loss of thymic negative selection, which leads to the appearance of T-cell clones with anti-host reactivity in vitro and in vivo.

Entities:  

Mesh:

Year:  2000        PMID: 10706060     DOI: 10.1097/00007890-200002150-00026

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  26 in total

1.  IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.

Authors:  Onder Alpdogan; Stephanie J Muriglan; Jeffrey M Eng; Lucy M Willis; Andrew S Greenberg; Barry J Kappel; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

2.  Rapidly proliferating CD44hi peripheral T cells undergo apoptosis and delay posttransplantation T-cell reconstitution after allogeneic bone marrow transplantation.

Authors:  S Onder Alpdogan; Sydney X Lu; Neel Patel; Suzanne McGoldrick; David Suh; Tulin Budak-Alpdogan; Odette M Smith; Jeremy Grubin; Christopher King; Gabrielle L Goldberg; Vanessa M Hubbard; Adam A Kochman; Marcel R M van den Brink
Journal:  Blood       Date:  2008-09-24       Impact factor: 22.113

3.  Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells.

Authors:  Simona W Rossi; Lukas T Jeker; Tomoo Ueno; Sachiyo Kuse; Marcel P Keller; Saulius Zuklys; Andrei V Gudkov; Yousuke Takahama; Werner Krenger; Bruce R Blazar; Georg A Holländer
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

4.  Donor T-cell alloreactivity against host thymic epithelium limits T-cell development after bone marrow transplantation.

Authors:  Mathias M Hauri-Hohl; Marcel P Keller; Jason Gill; Katrin Hafen; Esther Pachlatko; Thomas Boulay; Annick Peter; Georg A Holländer; Werner Krenger
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

5.  Administration of anti-CD20 mAb is highly effective in preventing but ineffective in treating chronic graft-versus-host disease while preserving strong graft-versus-leukemia effects.

Authors:  Heather F Johnston; Yajing Xu; Jeremy J Racine; Kaniel Cassady; Xiong Ni; Tao Wu; Andrew Chan; Stephen Forman; Defu Zeng
Journal:  Biol Blood Marrow Transplant       Date:  2014-05-04       Impact factor: 5.742

6.  Emergent autoimmunity in graft-versus-host disease.

Authors:  Elizabeth Tivol; Richard Komorowski; William R Drobyski
Journal:  Blood       Date:  2005-03-03       Impact factor: 22.113

7.  The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.

Authors:  Il-Kang Na; Sydney X Lu; Nury L Yim; Gabrielle L Goldberg; Jennifer Tsai; Uttam Rao; Odette M Smith; Christopher G King; David Suh; Daniel Hirschhorn-Cymerman; Lia Palomba; Olaf Penack; Amanda M Holland; Robert R Jenq; Arnab Ghosh; Hien Tran; Taha Merghoub; Chen Liu; Gregory D Sempowski; Melissa Ventevogel; Nicole Beauchemin; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

Review 8.  Chronic graft-versus-host disease: biological insights from preclinical and clinical studies.

Authors:  Kelli P A MacDonald; Geoffrey R Hill; Bruce R Blazar
Journal:  Blood       Date:  2016-11-07       Impact factor: 22.113

9.  Thymic damage, impaired negative selection, and development of chronic graft-versus-host disease caused by donor CD4+ and CD8+ T cells.

Authors:  Tao Wu; James S Young; Heather Johnston; Xiong Ni; Ruishu Deng; Jeremy Racine; Miao Wang; Audrey Wang; Ivan Todorov; Jianmin Wang; Defu Zeng
Journal:  J Immunol       Date:  2013-05-24       Impact factor: 5.422

Review 10.  T cell immune reconstitution following lymphodepletion.

Authors:  Kirsten M Williams; Frances T Hakim; Ronald E Gress
Journal:  Semin Immunol       Date:  2007-11-19       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.